Copyright
©The Author(s) 2016.
World J Gastroenterol. Mar 28, 2016; 22(12): 3451-3459
Published online Mar 28, 2016. doi: 10.3748/wjg.v22.i12.3451
Published online Mar 28, 2016. doi: 10.3748/wjg.v22.i12.3451
Table 2 Comparisons of changes in the gastrointestinal symptom scores of patients in each group (mean ± SD)
Symptom | Normal | IBS-D | UC in remission |
Abdominal pain or discomfort | 0.25 ± 0.05 | 1.84 ± 0.67a | 2.84 ± 0.81b |
Stool frequency | 0.55 ± 0.05 | 1.46 ± 0.58a | 2.34 ± 0.76b |
Stool | 0.75 ± 0.05 | 1.44 ± 0.67a | 1.89 ± 0.87b |
Mucus | 0.10 ± 0.03 | 1.04 ± 0.84b | 1.58 ± 0.67b |
Defecation | 0.55 ± 0.05 | 1.06 ± 0.74 | 1.86 ± 0.86b |
Total score | 1.75 ± 0.23 | 6.83 ± 1.86a | 9.51 ± 1.91b |
- Citation: Yu FY, Huang SG, Zhang HY, Ye H, Chi HG, Zou Y, Lv RX, Zheng XB. Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis. World J Gastroenterol 2016; 22(12): 3451-3459
- URL: https://www.wjgnet.com/1007-9327/full/v22/i12/3451.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i12.3451